Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04569747 |
|---|---|
| Brief Title: | A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer (ADEPT) |
| First Submitted : | September 25, 2020 |
| First Submitted that Met QC Criteria : | September 25, 2020 |
| First Posted : | September 30, 2020 |
| Last Update Submitted that Met QC Criteria : | April 24, 2024 |
| Last Update Posted : | April 25, 2024 |